These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
215 related articles for article (PubMed ID: 17894090)
1. On the coexistence of parkinsonism and tardive dyskinesia. Fann WE; Lake CR Dis Nerv Syst; 1974 Jul; 35(7):324-6. PubMed ID: 17894090 [No Abstract] [Full Text] [Related]
2. [Effect of the novel aminoadamantane derivative A-7 on Parkinsonian syndrome induced by systemic administration of neurotoxin MPTP]. Nerobkova LN; Val'dman EA; Voronina TA; Markina NV; Sharkova LM Eksp Klin Farmakol; 2000; 63(3):3-6. PubMed ID: 10934586 [TBL] [Abstract][Full Text] [Related]
3. Oculogyric dystonic states in early-onset parkinsonism with basal ganglia calcifications. Kis B; Hedrich K; Kann M; Schwinger E; Kömpf D; Klein C; Pramstaller PP Neurology; 2005 Sep; 65(5):761. PubMed ID: 16157916 [No Abstract] [Full Text] [Related]
4. Levodopa-induced dyskinesias in spinocerebellar ataxia type 2. Ferrara JM; Adam OR; Ondo WG Arch Neurol; 2010 Jan; 67(1):114-5. PubMed ID: 20065139 [No Abstract] [Full Text] [Related]
5. Pharmacological characterization of psychosis-like behavior in the MPTP-lesioned nonhuman primate model of Parkinson's disease. Visanji NP; Gomez-Ramirez J; Johnston TH; Pires D; Voon V; Brotchie JM; Fox SH Mov Disord; 2006 Nov; 21(11):1879-91. PubMed ID: 16960862 [TBL] [Abstract][Full Text] [Related]
6. [Influence of hemantane in injectable dosage form on levodopa-induced dyskinesia in rats with model parkinsonian syndrome]. Kapitsa IG; Ivanova EA; Kokshenev II; Nepoklonov AV; Val'dman EA; Voronina TA Eksp Klin Farmakol; 2014; 77(5):3-5. PubMed ID: 25033563 [TBL] [Abstract][Full Text] [Related]
11. Pharmacological management of psychosis in elderly patients with parkinsonism. Hasnain M; Vieweg WV; Baron MS; Beatty-Brooks M; Fernandez A; Pandurangi AK Am J Med; 2009 Jul; 122(7):614-22. PubMed ID: 19559160 [TBL] [Abstract][Full Text] [Related]
12. A controlled trial of amantadine hydrochloride and neuroleptics in the treatment of tardive dyskinesia. Angus S; Sugars J; Boltezar R; Koskewich S; Schneider NM J Clin Psychopharmacol; 1997 Apr; 17(2):88-91. PubMed ID: 10950469 [TBL] [Abstract][Full Text] [Related]
13. Commentary. Fox S Mov Disord; 2013 Aug; 28(9):1214-5. PubMed ID: 23857852 [No Abstract] [Full Text] [Related]
14. Antiparkinsonics, neuroleptics, and tardive dyskinesia. Mallya A; Jose C; Baig M; Williams R; Cho D; Mehta D; Volavka J Biol Psychiatry; 1979 Aug; 14(4):645-9. PubMed ID: 39640 [No Abstract] [Full Text] [Related]
15. Wearing-off phenomena and levodopa-induced dyskinesias in posttraumatic hemiparkinsonism. Pita Lobo P; Coelho M; Mestre TA; Rosa MM; Ferreira JJ Mov Disord; 2013 Aug; 28(9):1212-4. PubMed ID: 23861327 [No Abstract] [Full Text] [Related]
16. Improvement of freezing of gait with amantadine in a patient with oculopharyngeal muscular dystrophy and Parkinsonism. McGarry A; Biglan K Parkinsonism Relat Disord; 2013 Jun; 19(6):643-4. PubMed ID: 23561947 [No Abstract] [Full Text] [Related]
17. L-DOPA-induced dyskinesia: cellular mechanisms and approaches to treatment. Cenci MA Parkinsonism Relat Disord; 2007; 13 Suppl 3():S263-7. PubMed ID: 18267248 [TBL] [Abstract][Full Text] [Related]
18. HIV-associated Parkinsonism with levodopa-induced dyskinesia and response to highly-active antiretroviral therapy. Kobylecki C; Silverdale MA; Varma A; Dick JP; Kellett MW Mov Disord; 2009 Dec; 24(16):2441-2. PubMed ID: 19908326 [No Abstract] [Full Text] [Related]
19. [Comparative value of L-dopa, amantadine, anticholinergics, and their combinations in parkinsonian syndromes]. Ciuca I; Bulandra R; Serbanesco A; Ninosu N Rev Neurol (Paris); 1972 Aug; 127(2):305-8. PubMed ID: 4672049 [No Abstract] [Full Text] [Related]
20. [Present-day treatment of parkinsonism in the aged]. Siegfried J Schweiz Rundsch Med Prax; 1973 Oct; 62(40):1202-3. PubMed ID: 4754539 [No Abstract] [Full Text] [Related] [Next] [New Search]